Dr. Kannan Thanikachalam
Claim this profileThomas Hospital
Studies Pancreatic Cancer
Studies Gastroesophageal Junction Adenocarcinoma
5 reported clinical trials
16 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
BRCA1 positive
BRCA2 positive
2Gastroesophageal Junction Adenocarcinoma
BRCA1 positive
BRCA2 positive
PALB2 positive
Affiliated Hospitals
Clinical Trials Kannan Thanikachalam is currently running
Olaparib
for Pancreatic Cancer
This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.
Recruiting0 awards Phase 232 criteria
Chemotherapy Tailored by ctDNA Status
for Colon Cancer
This trial tests if a blood test for cancer DNA can help decide if colon cancer patients need more treatment after surgery. The test looks for cancer DNA in the blood to predict if the cancer might come back and to guide further treatment.
Recruiting1 award Phase 2 & 3
More about Kannan Thanikachalam
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Kannan Thanikachalam has experience with
- Gemcitabine
- Fluorouracil
- Nab Paclitaxel
- NovoTTF-100L(P)
- NovoTTF-200T
- CAPOX
Breakdown of trials Kannan Thanikachalam has run
Pancreatic Cancer
Gastroesophageal Junction Adenocarcinoma
Adenosquamous Carcinoma
Pancreatic Carcinoma
Pancreatic Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kannan Thanikachalam specialize in?
Kannan Thanikachalam focuses on Pancreatic Cancer and Gastroesophageal Junction Adenocarcinoma. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Kannan Thanikachalam currently recruiting for clinical trials?
Yes, Kannan Thanikachalam is currently recruiting for 3 clinical trials in Fairhope Alabama. If you're interested in participating, you should apply.
Are there any treatments that Kannan Thanikachalam has studied deeply?
Yes, Kannan Thanikachalam has studied treatments such as Gemcitabine, Fluorouracil, nab paclitaxel.
What is the best way to schedule an appointment with Kannan Thanikachalam?
Apply for one of the trials that Kannan Thanikachalam is conducting.
What is the office address of Kannan Thanikachalam?
The office of Kannan Thanikachalam is located at: Thomas Hospital, Fairhope, Alabama 36532 United States. This is the address for their practice at the Thomas Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.